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Static light scattering, small angle X-ray scattering and viscosity measure-
ments as a function of protein concentration are used to semi-quantitatively
correlate the oligomeric state of an IgG1 antibody (mAb1) with its rheolog-
ical behavior at solution pH 6.0 and varying ionic strength. Solution SAXS
coupled with optimized ensemble minimization was used to determine that
reversible mAb1 dimers form with extended structures in dilute solutions.
Light scattering measurements over a wide range of mAb1concentrations
(1- 175 mg/mL) provide detailed information on the equilibrium thermody-
namic interactions and their modulation by modest increases of ionic
strength. By applying interacting hard sphere models to fit the concentration
dependence of light scattering data, we observe the formation of equilibrium
protein clusters (depending on solution conditions) of 2- 8 mAb1 molecules.
Protein cluster size was found to be directly linked to concentrated IgG solu-
tion viscosities, which increased from 52 to 450 cP. Analysis of mAb1 solu-
tion viscosities as a function of ionic strength also established that effective
molecular sizes under constant sheer conditions increased with protein con-
centration. Collectively, the results reveal that the formation of elongated,
oligomeric structures increase mAb1 solution viscosities at high concentra-
tions, and suggest that only a small set of anisotropic interactions between
complimentary hydrophobic surfaces are required to nucleate and propagate
protein clusters.
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Intrinsically disordered proteins have very important flexible structures. In
order to analyze such proteins, we need new methodology for high-accuracy
measurements of three- dimensional (3D) intra-molecular motions. The struc-
ture of tau proteins in solution resembles that of a random coil. But, tau proteins
in Alzheimer paired helical filaments-like fibers have very little secondary
structures. Here, we observed the 3D structural motions of tau proteins using
Diffracted X-ray Tracking (DXT) as high-speed x-ray single molecule obser-
vations. In DXT, we observed Brownian motions of recombinant tau proteins
and his-tagged tau proteins, which are adsorbed on the substrate’s surface.
These adsorbed tau proteins was reacted to many antibodies and was phosphor-
ylated by several kinases. We succeeded in measuring three-dimensional
(3D= 2 axes as polar coordinates) micro-second super-high accuracy (pico-
meter scale) motion maps of individual single molecule observations at
many conditions of the tau proteins. From dynamic DXT data, for example,
the tau protein combined with the antibody was confirmed that structure fluc-
tuation had become slightly large compared with that which is not combined.
We discuss the aggregation process of tau protein from these dynamic intra-
molecular data under many conditions.
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Self-assembling amphiphilic designer-peptides are used as building blocks for
the development of controllable, tailor-made biomaterials. In solution, they
self-assemble above a critical aggregation concentration into supramolecular
structures, like vesicles, bilayers, twisted tapes, fibers or tubes. In this study
we investigated the concentration- and time-dependent self-assembly of an
8-residue amphiphilic designer-peptide. We observed structural transitions
from peptide monomers to elongated pairwise aligned tapes. Highly concen-
trated samples assembled into the first double helix superstructure that was
observed within the class of amphiphilic designer-peptides so far. Synchrotronsmall angle X-ray scattering provided a detailed insight into the internal
organization of the double helix. The obtained electron-density-profile sug-
gested a 3-shell-model, mirrored at the central axis. Shell 1 (~1 nm) and shell
2 (~3.5 nm) together account for the peptide containing region, where the hy-
drophobic parts of the peptide monomers were interdigitated and tightly
packed. In the innermost region we confirmed antiparallel stacking due to inter-
molecular hydrogen bonding by circular dichroism and infrared spectroscopy.
Shell 3 spans around 12 nm and was assigned to a hydration shell where
negatively charged trifluoroacetate counter ions preferably attach to the posi-
tively charged peptide headgroups. The total diameter of the double helix
was 24 nm, with a repeating pitch distance of ~60 nm. Cryo transmission elec-
tron microscopy supported the double helix morphology and revealed that their
lengths extended to several hundreds of nanometers. The double helices were
intertwined into a tight network. The resulting hydrogel properties may lead
to promising future applications.
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Systemic light chain amyloidosis (AL amyloidosis) is a rare but fatal sys-
temic amyloid disease. It usually strikes in the wake of myeloma, a form
of cancer that affects plasma cells in the adaptive immune system. During
plasma cell development from primary B cells, the immunoglobulin light
chain (LC) genes undergo several rearrangements that leave each cell with
a unique version of the protein. In myelomas one plasma cell clone rapidly
reproduces itself. Instead of fulfilling their former immunological role, the
LCs cluster into amyloid. A similar process underlies the Multiple Myeloma
(MM) pathology, but here the protein does not go on to form amyloid. Our
study aims to understand the biophysical basis of this difference between
AL and MM.
In both diseases large amounts of soluble LC are secreted into circulation and
excreted with urine. Hence we hypothesize that amyloid deposition depends
on the amyloid formation propensity of the individual LC sequences rather
than being a result of different LC concentrations being present in both dis-
eases. To test this hypothesis we used a simple purification strategy to isolate
LC from urine of patients suffering from the two diseases, excluding cases
where renal failure was indicated. We then recorded aggregation kinetics at
multiple concentrations in vitro to quantify the stabilities and aggregation pro-
pensities of the individual LC proteins. We found that LC protein from AL
and MM patients both formed amyloid fibrils at comparable concentrations,
but with different aggregation rates, suggesting that amyloid formation may
be kinetically inhibited in MM patients. We will now expand the study to a
larger group of patients and derive LC sequences from bone marrow. We
hope to establish a correlation between specific differences in sequences
and clinical parameters in AL and MM, which could enable a more personal-
ized treatment of patients.
318-Pos Board B73
Aggregation of Therapeutic Antibodies: AMultiscale Molecular Dynamics
Approach
David Shorthouse1, Jesus Zurdo2, Mark Sansom1.
1University of Oxford, Oxford, United Kingdom, 2Lonza Biologics,
Cambridge, United Kingdom.
Aggregation is a major challenge in the development of antibody-based ther-
apeutics. Therapeutic antibodies are produced and stored in high concentra-
tions and generated under varying and unfavourable conditions for the
stability of monomeric proteins. The aggregation of these proteins in solution
can lead to serious consequences for patients in the form of the initiation of
immune reactions, which have the potential to be fatal, and in the loss of
clinical potency. Further to this, the type of aggregates formed by antibodies,
and the processes that lead to their propagation, are relatively poorly under-
stood. Thus by investigating these molecules as a model system we may
find out more about other, more complex systems known to involve aggrega-
tion - including amyloids. Here we apply multiscale molecular dynamics
simulations to investigate the aggregation of antibody fragments. Using
coarse-grained molecular dynamics (CG-MD) we are able to access much
longer timescales than traditional atomistic methodologies, and to look at
much larger ensembles of proteins. We are also able to glycosylate these
models, and convert structures back to atomistic detail. CG simulations of
systems containing 2 protein fragments give us insights into the specific in-
teractions and, which surfaces on the molecular structures are involved in
them. Simulations of much larger ensembles of proteins (from 4 and up to
16 antibody fragments) allow us to look the formation of larger aggregates,
